Pro Share Advisors LLC Axsome Therapeutics, Inc. Transaction History

Pro Share Advisors LLC

  • $42.5 Billion
  • Q4 2024

A detailed history of Pro Share Advisors LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 12,664 shares of AXSM stock, worth $1.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,664
Previous 9,722 30.26%
Holding current value
$1.66 Million
Previous $873,000 22.68%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$83.08 - $100.49 $244,421 - $295,641
2,942 Added 30.26%
12,664 $1.07 Million
Q3 2024

Nov 13, 2024
BUY
$78.93 - $95.84 $159,043 - $193,117
2,015 Added 26.15%
9,722 $873,000
Q2 2024

Aug 13, 2024
SELL
$65.72 - $80.5 $132,557 - $162,368
-2,017 Reduced 20.74%
7,707 $620,000
Q1 2024

May 08, 2024
BUY
$69.39 - $97.64 $55,512 - $78,112
800 Added 8.96%
9,724 $775,000
Q4 2023

Feb 14, 2024
BUY
$57.42 - $83.61 $72,808 - $106,017
1,268 Added 16.56%
8,924 $710,000
Q3 2023

Nov 13, 2023
BUY
$69.25 - $82.21 $38,641 - $45,873
558 Added 7.86%
7,656 $535,000
Q2 2023

Aug 10, 2023
BUY
$58.41 - $90.35 $18,048 - $27,918
309 Added 4.55%
7,098 $510,000
Q1 2023

May 11, 2023
SELL
$58.39 - $75.0 $54,069 - $69,450
-926 Reduced 12.0%
6,789 $418,000
Q4 2022

Feb 02, 2023
BUY
$39.94 - $79.72 $41,817 - $83,466
1,047 Added 15.7%
7,715 $595,000
Q3 2022

Nov 04, 2022
BUY
$36.06 - $69.85 $14,964 - $28,987
415 Added 6.64%
6,668 $297,000
Q2 2022

Aug 01, 2022
SELL
$21.74 - $46.75 $62,285 - $133,938
-2,865 Reduced 31.42%
6,253 $239,000
Q1 2022

May 10, 2022
SELL
$23.7 - $41.39 $53,680 - $93,748
-2,265 Reduced 19.9%
9,118 $378,000
Q4 2021

Feb 08, 2022
SELL
$30.7 - $43.36 $6,907 - $9,756
-225 Reduced 1.94%
11,383 $430,000
Q3 2021

Nov 12, 2021
SELL
$19.91 - $68.26 $46,788 - $160,411
-2,350 Reduced 16.84%
11,608 $383,000
Q2 2021

Aug 13, 2021
BUY
$50.63 - $73.5 $70,173 - $101,871
1,386 Added 11.02%
13,958 $942,000
Q1 2021

May 14, 2021
BUY
$55.91 - $81.44 $37,571 - $54,727
672 Added 5.65%
12,572 $712,000
Q4 2020

Feb 09, 2021
BUY
$66.31 - $86.52 $165,642 - $216,126
2,498 Added 26.57%
11,900 $969,000
Q3 2020

Nov 13, 2020
SELL
$68.34 - $85.84 $19,886 - $24,979
-291 Reduced 3.0%
9,402 $670,000
Q2 2020

Aug 03, 2020
BUY
$49.87 - $98.69 $167,812 - $332,091
3,365 Added 53.18%
9,693 $798,000
Q1 2020

May 15, 2020
SELL
$41.2 - $101.31 $187,254 - $460,453
-4,545 Reduced 41.8%
6,328 $372,000
Q4 2019

Feb 12, 2020
BUY
$16.71 - $106.24 $181,687 - $1.16 Million
10,873 New
10,873 $1.12 Million

Others Institutions Holding AXSM

# of Institutions
348
Shares Held
36.2M
Call Options Held
1.32M
Put Options Held
1M
View Full List

About Axsome Therapeutics, Inc.

AXSM Quotes by TradingView
  • Ticker AXSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,878,000
  • Market Cap $5.62B
  • Description
  • Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...
More about AXSM
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email